These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 34038713)

  • 1. Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.
    Siddhartha R; Garg M
    Toxicol Appl Pharmacol; 2021 Sep; 426():115593. PubMed ID: 34038713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seesaw of matrix metalloproteinases (MMPs).
    Kapoor C; Vaidya S; Wadhwan V; ; Kaur G; Pathak A
    J Cancer Res Ther; 2016; 12(1):28-35. PubMed ID: 27072206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Matrix Metalloproteinases in Oral Diseases.
    Maciejczyk M; Pietrzykowska A; Zalewska A; Knaś M; Daniszewska I
    Adv Clin Exp Med; 2016; 25(2):383-90. PubMed ID: 27627574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and cancer - roles in threat and therapy.
    Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
    Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases: regulators of the tumor microenvironment.
    Kessenbrock K; Plaks V; Werb Z
    Cell; 2010 Apr; 141(1):52-67. PubMed ID: 20371345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].
    Naduk-Kik J; Hrabec E
    Postepy Hig Med Dosw (Online); 2008 Sep; 62():442-50. PubMed ID: 18772849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).
    Almutairi S; Kalloush HM; Manoon NA; Bardaweel SK
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W; Saji S; Sato F; Noda M; Toi M
    Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinases: A challenging paradigm of cancer management.
    Alaseem A; Alhazzani K; Dondapati P; Alobid S; Bishayee A; Rathinavelu A
    Semin Cancer Biol; 2019 Jun; 56():100-115. PubMed ID: 29155240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases in tumorigenesis: an evolving paradigm.
    Hua H; Li M; Luo T; Yin Y; Jiang Y
    Cell Mol Life Sci; 2011 Dec; 68(23):3853-68. PubMed ID: 21744247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
    Bourboulia D; Stetler-Stevenson WG
    Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.